tiprankstipranks
Trending News
More News >

FendX Technologies Responds to CDC’s Antimicrobial Resistance Report with Innovative Solutions

Story Highlights
FendX Technologies Responds to CDC’s Antimicrobial Resistance Report with Innovative Solutions

Don’t Miss TipRanks’ Half-Year Sale

FendX Technologies, Inc. ( (TSE:FNDX) ) just unveiled an update.

FendX Technologies Inc. highlights the CDC’s recent reports on the growing threat of antimicrobial resistance, emphasizing the rise of drug-resistant infections like Candida auris. The company is actively developing surface protection products, including REPELWRAP™ film, to combat the spread of pathogens. FendX is also expanding its portfolio through business development initiatives, such as a recent agreement with US BioSolutions to acquire intellectual property for an eco-friendly sponge. These efforts aim to enhance FendX’s market positioning in the fight against antimicrobial resistance.

More about FendX Technologies, Inc.

FendX Technologies Inc. is a Canada-based nanotechnology company focused on developing products to reduce the spread of pathogens. The company is working on surface protection products such as the REPELWRAP™ film and a bifunctional spray coating, both designed to prevent pathogen adhesion and reduce contamination. FendX collaborates with industry-leading partners like McMaster University and holds exclusive worldwide licenses for its technology.

YTD Price Performance: -47.06%

Average Trading Volume: 99,038

Technical Sentiment Signal: Strong Buy

See more insights into FNDX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1